SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 100 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 5.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,915 | -88.1% | 4,419 | -78.9% | 0.00% | – |
| Q3 2022 | $33,000 | -25.0% | 20,984 | -4.6% | 0.00% | – |
| Q2 2022 | $44,000 | +238.5% | 21,987 | +293.3% | 0.00% | – |
| Q1 2022 | $13,000 | +225.0% | 5,591 | +1294.3% | 0.00% | – |
| Q2 2021 | $4,000 | -99.7% | 401 | -99.9% | 0.00% | – |
| Q3 2018 | $1,599,000 | +271.9% | 363,300 | +233.9% | 0.00% | – |
| Q1 2017 | $430,000 | +20.1% | 108,789 | +164.5% | 0.00% | – |
| Q4 2015 | $358,000 | +3.8% | 41,130 | 0.0% | 0.00% | – |
| Q3 2015 | $345,000 | -52.4% | 41,130 | 0.0% | 0.00% | – |
| Q2 2015 | $725,000 | +52.6% | 41,130 | 0.0% | 0.00% | – |
| Q1 2015 | $475,000 | -75.2% | 41,130 | -90.3% | 0.00% | – |
| Q3 2014 | $1,916,000 | -55.7% | 423,800 | -33.9% | 0.00% | -100.0% |
| Q2 2014 | $4,327,000 | -48.1% | 641,100 | -1.4% | 0.00% | 0.0% |
| Q1 2014 | $8,333,000 | +58.3% | 650,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $5,265,000 | – | 650,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Oaktree Fund Advisors, LLC | 66,000 | $503,000 | 48.93% |
| SABBY MANAGEMENT, LLC | 1,698,107 | $12,957,000 | 1.75% |
| EMFO, LLC | 233,008 | $1,778,000 | 1.57% |
| swisspartners Ltd. | 110,000 | $839,000 | 0.65% |
| HERITAGE WEALTH MANAGEMENT, LLC | 150,000 | $1,145,000 | 0.41% |
| Donald L. Hagan, LLC | 42,929 | $328,000 | 0.19% |
| COLLECTIVE FAMILY OFFICE LLC | 44,203 | $337,000 | 0.14% |
| Spectrum Wealth Advisory Group, LLC | 18,093 | $138,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 100,000 | $763,000 | 0.13% |
| Cormorant Asset Management, LP | 400,000 | $3,052,000 | 0.12% |